We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

The Role of N-terminus of Plasmodium Falciparum ORC1 in Telomeric Localization and Var Gene Silencing

News   Mar 07, 2012

 
The Role of N-terminus of Plasmodium Falciparum ORC1 in Telomeric Localization and Var Gene Silencing
 
 
Advertisement
 

RELATED ARTICLES

Dutch Vico Therapeutics Appoints Rupert Sandbrink and Anders Hinsby as CMO and Independent Director

News

Vico Therapeutics, a biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, announced the appointment of Rupert Sandbrink, M.D., Ph.D., as the company’s chief medical officer and Anders Hinsby, Ph.D., as independent Director on the 1st October.

READ MORE

Study Confirms Efficacy of Gene Therapy for Spinal Muscular Atrophy in Children

News

A new study has explored safety and early outcomes in a large cohort of SMA patients under the age of two years who were treated with gene therapy.

READ MORE

New Breast Cancer Database Could Help To Develop Personalized Treatments

News

A new database of 40 breast cancer cell lines aims to help researchers deepen their understanding of these cell lines and speed up the development of new gene-targeted therapies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE